This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Palomar (PLMR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Palomar (PLMR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hartford Financial (HIG) Q2 Earnings Beat on Commercial Lines
by Zacks Equity Research
Hartford Financial's (HIG) quarterly earnings benefit from a strong Group Benefits and Commercial Lines performance. However, rising expenses partially offset the positives.
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Cincinnati Financial (CINF) Q2 Earnings Beat Estimates
by Zacks Equity Research
Cincinnati Financial (CINF) delivered earnings and revenue surprises of 32.99% and 1.61%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Can Hartford Financial (HIG) Counter Rising Costs in Q2 Earnings?
by Zacks Equity Research
Hartford Financial's (HIG) Q2 results are likely to reflect benefits of new business growth and favorable retention rates in the Commercial Lines unit, partly offset by an elevated expense level.
Will Rising Expenses Play Spoilsport for AON's Q2 Earnings?
by Zacks Equity Research
AON's second-quarter results are likely to reflect growing contributions from its Health Solutions unit.
Here's Why Wait & See Style Is Apt for First American (FAF)
by Zacks Equity Research
First American (FAF) remains well-poised to capitalize on the increased demand for first-time home purchases among millennials.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Are You Looking for a Top Momentum Pick? Why Palomar (PLMR) is a Great Choice
by Zacks Equity Research
Does Palomar (PLMR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Palomar (PLMR) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Palomar (PLMR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AXIS Capital (AXS) Rises 30% YTD: What's Driving the Stock?
by Zacks Equity Research
AXIS Capital (AXS) continues to build on specialty insurance, reinsurance as well as the accident and health portfolio. An improved portfolio mix and effective capital deployment should drive growth.
How to Find Strong Buy Finance Stocks Using the Zacks Rank
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Travelers (TRV) Rises 21% in a Year: More Room for Growth?
by Zacks Equity Research
Travelers (TRV) is set to gain from strong renewal rate change, solid retention, increase in new business supported by a compelling portfolio and a solid capital position.
Palomar Holdings (PLMR) Rises 43% in a Year: What's Driving It?
by Zacks Equity Research
Palomar Holdings (PLMR) gains from new business, strong retention rates, expansion of products??? geographic and distribution footprint, new partnerships and high-quality fixed-income securities.
Marsh & McLennan (MMC) Unit Sustains Its Acquisition Spree
by Zacks Equity Research
Marsh & McLennan's (MMC) unit, MMA, is set to enhance its risk management capabilities with the acquisition of Horton. This strategic move is part of MMA's ongoing expansion strategy.
Why You Should Stay Invested in Arch Capital (ACGL) Stock
by Zacks Equity Research
Arch Capital (ACGL) remains poised to gain from new business opportunities, rate improvement, favorable estimates and a solid capital position.
Unum (UNM) to Divest Medical Stop Loss Business to Amynta Group
by Zacks Equity Research
Unum's (UNM) decision to divest its Medical Stop Loss business to Amynta Group will help the insurer intensify its focus on its strategic growth priorities.
Aflac (AFL), SKYGEN Team Up to Enhance Dental and Vision Services
by Zacks Equity Research
Aflac (AFL) joins forces with SKYGEN to improve dental and vision benefit management, boosting customer satisfaction and AFL's product sales through advanced technology and streamlined processes.
Here's Why You Should Retain Cincinnati Financial (CINF) Stock
by Zacks Equity Research
Cincinnati Financial (CINF) is set to grow on higher level of insured exposure, rate increase, agent-focused business model, consistent cash flow and a solid capital position.
Reasons Why Investors Should Consider Buying RLI Stock Now
by Zacks Equity Research
RLI stands to gain from a compelling product portfolio, rise in rate, improved retention, higher premium receipts, sufficient liquidity and effective capital deployment.
Is Oscar Health (OSCR) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Oscar Health, Inc. (OSCR) and Palomar (PLMR) have performed compared to their sector so far this year.
Here's Why You Should Stay Invested in Trupanion (TRUP) Stock
by Zacks Equity Research
Trupanion (TRUP) is poised to grow on its focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position
Here's Why You Should Retain Hanover Insurance (THG) Stock
by Zacks Equity Research
Hanover Insurance (THG) stands to gain from growth in the Core Commercial and Specialty segments, stable retention, better pricing, strong market presence and solid capital position.
Why You Should Hold American International (AIG) Stock Now
by Zacks Equity Research
American International (AIG) is expected to benefit from rising premiums in the General Insurance business, improving investment income, enhanced savings from AIG Next, and streamlining initiatives.
Why Should You Stay Invested in Fidelity National (FNF) Stock?
by Zacks Equity Research
Fidelity National Financial (FNF) is set to grow from its market-leading position, higher direct premiums, agency premiums, strong origination demand and effective capital deployment.